Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake.
about
Selective condensation of DNA by aminoglycoside antibioticsCoagulase-negative Staphylococci favor conversion of arginine into ornithine despite a widespread genetic potential for nitric oxide synthase activity.Salmonella-how a metabolic generalist adopts an intracellular lifestyle during infection.Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas aeruginosa biofilms.Nitric oxide from IFNγ-primed macrophages modulates the antimicrobial activity of β-lactams against the intracellular pathogens Burkholderia pseudomallei and Nontyphoidal SalmonellaMethicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development.TCA cycle inactivation in Staphylococcus aureus alters nitric oxide production in RAW 264.7 cells.Persister formation in Escherichia coli can be inhibited by treatment with nitric oxide.Nitrate, nitrite and nitric oxide reductases: from the last universal common ancestor to modern bacterial pathogens.Efficient Eradication of Mature Pseudomonas aeruginosa Biofilm via Controlled Delivery of Nitric Oxide Combined with Antimicrobial Peptide and Antibiotics.The ABC-type efflux pump MacAB protects Salmonella enterica serovar typhimurium from oxidative stress.Nitrite produced by Mycobacterium tuberculosis in human macrophages in physiologic oxygen impacts bacterial ATP consumption and gene expression.Bacterial iron-sulfur regulatory proteins as biological sensor-switchesPhylogenomics of Mycobacterium Nitrate Reductase Operon.The Staphylococcus aureus α-Acetolactate Synthase ALS Confers Resistance to Nitrosative Stress.The 'liaisons dangereuses' between iron and antibiotics.Environmental and genetic modulation of the phenotypic expression of antibiotic resistance.Response to Gaseous NO2 Air Pollutant of P. fluorescens Airborne Strain MFAF76a and Clinical Strain MFN1032.Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.Novel Pathways for Ameliorating the Fitness Cost of Gentamicin Resistant Small Colony Variants.Sodium nitrite blocks the activity of aminoglycosides against Pseudomonas aeruginosa biofilms.Nitric oxide-releasing polyacrylonitrile disperses biofilms formed by wound-relevant pathogenic bacteria.Nitric oxide and salmonella pathogenesis.Nitric oxide-dependent killing of aerobic, anaerobic and persistent Burkholderia pseudomallei.Comparison of transcriptomes of wild-type and isothiazolone-resistant Pseudomonas aeruginosa by using RNA-seq.Staphylococcus aureus nitric oxide synthase (saNOS) modulates aerobic respiratory metabolism and cell physiology.Antibiotic efficacy in the complex infection environment.
P2860
Q27324035-1BBDD11E-CAC3-4633-8C08-E740DEBBA760Q34595505-DE6B6827-AECE-4B28-B9CC-837CEE6FC5C4Q35026100-3CA17CE6-6FE3-4999-8EA1-A311C173B228Q35071144-CB4AB1CD-6C7D-4D42-BEA3-F80BFCE8007EQ35224538-67BFCC04-FB9A-4281-B18E-07E483367D63Q36647337-2C5642EE-4455-4E1B-8E35-A55D285F2C3EQ36685764-047628E8-10BF-4F74-BF29-58239A7A840FQ36982370-15613022-22F3-4BDB-8A7C-E33EB68AC426Q37058824-FFC8FDC4-DCD9-46D7-9A8D-48A87D825D8AQ37182594-92697F96-A8AC-4D59-9405-2C734A47BA7BQ37258660-EE4E651B-9496-40F7-A461-50DA5B0F45E1Q37318269-2AB0DB77-0154-49A0-BB14-13B29589F565Q37975225-25F8BF2E-73F4-4F01-8072-4800C3B8988FQ38484210-E631ED20-6A7D-44AD-9892-3D90742D22FAQ38661286-74B66813-40C8-4AAA-94FF-78581A634CC3Q38761978-48C9D4DC-42AB-4D24-A0AB-E8852EA10AB1Q39195574-069171C4-C9A0-4085-A303-8EFCC1F56064Q39701994-E0088F11-1A8B-42A0-9E52-68B3159492A4Q40074209-72BAD571-8827-4076-B293-03BE5C14C3C5Q40116694-07F3C39C-A958-4B14-B15C-9FCAD5A9363BQ40422526-12F01BE1-BF38-43A7-9587-F6AA8AAC4E53Q40677387-4118D009-FD4B-4658-9AB0-32F42146B92BQ40827021-0175F063-0045-4149-80A4-C290B6B40BDBQ42100653-67F33705-F83F-4342-94B4-FB870D830108Q42198497-AED57897-F77E-4438-BDA2-3AA8250BDDE0Q42773423-FAA4AD31-7BB7-4408-8780-3FF68E5E3F10Q46379131-DC2111D9-7A9D-4336-BACD-BE6E7E6FD6DDQ49502887-DE3B824C-10C8-4A67-B6CF-0A67939BFADF
P2860
Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Nitric oxide protects bacteria ...... pendent phases of drug uptake.
@ast
Nitric oxide protects bacteria ...... pendent phases of drug uptake.
@en
Nitric oxide protects bacteria ...... pendent phases of drug uptake.
@nl
type
label
Nitric oxide protects bacteria ...... pendent phases of drug uptake.
@ast
Nitric oxide protects bacteria ...... pendent phases of drug uptake.
@en
Nitric oxide protects bacteria ...... pendent phases of drug uptake.
@nl
prefLabel
Nitric oxide protects bacteria ...... pendent phases of drug uptake.
@ast
Nitric oxide protects bacteria ...... pendent phases of drug uptake.
@en
Nitric oxide protects bacteria ...... pendent phases of drug uptake.
@nl
P2093
P2860
P356
P1476
Nitric oxide protects bacteria ...... pendent phases of drug uptake.
@en
P2093
Andrés Vázquez-Torres
Bruce D McCollister
Maroof Husain
Matthew Hoffman
P2860
P304
P356
10.1128/AAC.01203-10
P407
P577
2011-02-22T00:00:00Z